Introduction: Andersen-Tawil Syndrome (ATS) is a rare genetic disorder characterized by ventricular arrhythmias, muscle weakness and dysmorphic features. There are no specific guidelines for implantation of ICD devices in this population. In this study, we determined the incidence of device therapy, burden of arrhythmias, indication for implant and device complications. Methods: Our ATS registry consists of 147 patients including 52 patients with cardiac manifestations (ventricular arrhythmias, syncope and/ or ICDs). The group ranged in age from 12-84 yrs (mean 38 yrs; 81 % female) with follow-up of 11 yrs ±12. The database was examined for ICD implants, therapy and complications. 16/52 ATS subjects with cardiac manifestations received an ICD.
